# An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

> **NCT00806546** · PHASE3 · COMPLETED · sponsor: **NuPathe Inc.** · enrollment: 514 (actual)

## Conditions studied

- Migraine Disorders

## Interventions

- **DRUG:** NP101

## Key facts

- **NCT ID:** NCT00806546
- **Lead sponsor:** NuPathe Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 514 (ACTUAL)
- **Last updated:** 2016-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00806546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00806546, "An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00806546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*